When Do You Start Losing Weight on Wegovy

Early weight movement (weeks 1–4) is real but modest, the appetite-suppressing effect begins even at the starter dose.
The 2.4 mg maintenance dose, reached after several months of titration, is when most trial participants saw their largest monthly losses.
In the STEP 1 clinical trial, participants lost an average of around 15% of body weight over 68 weeks, weight change accumulates throughout treatment, not all at once.
Factors including starting BMI, diet, activity levels and how well doses are tolerated all shape how quickly the numbers move for any individual.

Most people begin to see the scale move within the first two to four weeks on Wegovy, though meaningful fat loss — the kind you notice in how clothes fit — tends to build from weeks four to eight onward. Weight loss on semaglutide is gradual by design: the titration schedule keeps doses low at the start to let your body adjust, which means the biggest reductions come later in treatment. These are prescription-only medicines; a prescriber decides whether Wegovy is right for you after a clinical assessment, and the timeline you experience will depend on your dose, your starting point and how your body responds.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How weight loss unfolds across the Wegovy titration journey

The first few weeks: appetite shifts before the scale does

Picture the moment you sit down for dinner in week two and realise, genuinely, that you don't want to finish your plate. That shift in appetite is often the first sign Wegovy is working, and it tends to arrive before any meaningful number appears on the scales. At the 0.25 mg starting dose, semaglutide is already slowing gastric emptying and acting on the brain's appetite centres; the weight response just takes a little longer to catch up.

For most people, the first measurable loss (somewhere between one and three kilograms) appears by the end of weeks two to four. That figure sounds modest, and it is. One misconception worth letting go of: an early slow start does not mean the medicine isn't working. The titration exists partly to reduce nausea, which means the body is deliberately kept at sub-therapeutic doses for the first couple of months. You can read more about how the early weeks of Wegovy compare to expectations if the first month feels quieter than you'd hoped.

Gastrointestinal side effects (nausea, loose stools, a sense of fullness that arrives fast) are most common at this stage, per the NHS semaglutide medicines page. They typically ease as the body settles into the dose.

Months two to six: when most people start losing weight with Wegovy in earnest

The titration schedule moves through 0.5 mg, then 1.0 mg, then 1.7 mg, with roughly four weeks at each step. By months three and four, most people are approaching or at 1.7 mg, and this is usually when weekly losses become more consistent and noticeable. Clothes start fitting differently. Energy levels often improve alongside appetite control.

The full 2.4 mg maintenance dose (the level studied in most of the major trials) typically isn't reached until around month five. That matters, because the STEP 1 trial, published in the New England Journal of Medicine and involving nearly 2,000 adults with obesity, recorded an average body-weight reduction of around 15% over 68 weeks at 2.4 mg. The bulk of that loss happened in the back half of the trial, not the front. So if you're asking when people start losing weight on Wegovy relative to where their loss peaks, the honest answer is: the start is early, the peak is later.

If you're weighing up Wegovy against other options, our overview of licensed weight-loss treatments explains how semaglutide sits alongside other medicines currently available in the UK.

What affects your personal timeline on semaglutide

Two people on identical doses can have meaningfully different timelines. Starting BMI plays a role, those with higher starting weights often see larger absolute losses early on, though percentage losses tend to converge over time. Dietary change matters a great deal; Wegovy works alongside a reduced-calorie diet and increased activity, not instead of them. Protein intake, hydration and consistent movement all support the medicine's effect.

Tolerability is another variable. If nausea is significant, staying longer at a lower dose is sometimes the right clinical call, even if it pushes back the point at which you reach the higher, more effective doses. A prescriber who knows your history can make that judgement. Dose increases should always be guided clinically; details of the titration schedule are set out in the Patient Information Leaflet and reviewed by your prescriber at each step.

It's also worth knowing that the question of when weight loss begins on semaglutide is slightly different from when you'll notice it. The physiological changes start almost immediately; the visible ones take a few weeks longer. Both timelines are normal.

For a broader look at what the evidence says about Wegovy's licensed use and results in the UK, the NICE appraisal of semaglutide (TA875) is the authoritative reference.

Staying on track: the longer view

Weight loss on Wegovy is not linear. Weeks where nothing moves on the scale are common and don't signal failure. The clinical evidence covers 68 weeks and beyond, and the data show continued loss well into year one for most participants. If you're curious about when you really start losing weight on Wegovy and what the evidence says about meaningful progress, it's worth understanding that individual variation is wide and a slow start rarely predicts a poor overall outcome. If loss stalls entirely after six months at the maintenance dose, that is a clinical signal worth discussing, and our guide on when you should expect to start losing weight on Wegovy can help you understand what counts as a normal timeline before raising concerns with your prescriber. NICE guidance notes that continuing treatment should be reviewed if less than 5% weight loss has occurred by that point.

Wondering about the cost of staying on treatment long enough to reach that phase? Our guide to Wegovy pricing in the UK covers what private treatment typically costs and what should be included in any legitimate quote. And if you're ready to take a clinical look at whether Wegovy suits your situation, our prescribers are available to assess your eligibility through a free consultation. A real clinician reads every assessment the same day, no automated decisions, no queues.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions